High flow nasal cannula in older vulnerable COVID-19 patients: A missed opportunity? - 08/12/21
Doi : 10.1016/j.rmed.2021.106666
Ruth A.L. Willems
Department of Internal Medicine, Division of General Internal Medicine, Section Geriatric Medicine, Maastricht University Medical Center, Maastricht, the Netherlands
Bart Spaetgens
Department of Internal Medicine, Division of General Internal Medicine, Section Geriatric Medicine, Maastricht University Medical Center, Maastricht, the Netherlands
Cardiovascular Research Institute Maastricht (CARIM), Maastricht, the Netherlands
Lennart H. Conemans, Geertjan Wesseling
Department of Respiratory Medicine, Maastricht University Medical Center, Maastricht, the Netherlands
Coen D.A. Stehouwer
Department of Internal Medicine, Division of General Internal Medicine, Maastricht University Medical Center, Maastricht, the Netherlands
Cardiovascular Research Institute Maastricht (CARIM), Maastricht, the Netherlands
Teba Alnima ⁎ 
Department of Internal Medicine, Division of General Internal Medicine, Section Vascular Medicine, Maastricht University Medical Center, Maastricht, the Netherlands
∗Corresponding author. Maastricht University Medical Center (MUMC+), Department of Internal Medicine, P.O. Box 5800, 6202, AZ Maastricht, the Netherlands.Maastricht University Medical Center (MUMC+)Department of Internal MedicineP.O. Box 5800AZ Maastricht6202the Netherlands
Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.
Connectez-vous pour en bénéficier!
Keywords : COVID-19, Respiratory insufficiency, Frailty, High flow nasal cannula
Le texte complet de cet article est disponible en PDF.
© 2021
Elsevier Ltd. Tous droits réservés.
Vol 189
Article 106666- novembre 2021 Retour au numéro
Article précédent
- Hypoxemia severity and survival in ILD and COPD on long-term oxygen therapy – The population-based DISCOVERY study
- Andreas Palm, Magnus Ekström
Bienvenue sur EM-consulte, la référence des professionnels de santé.